Leena Ylösmäki

Leena Ylösmäki, Director of Pre-clinical Development, has over 15 years of experience in the fields of basic and applied virology and cancer research. During her academic career, she has studied various different viruses including Influenza A, vaccinia and adenoviruses. Before joining Valo Therapeutics, Leena worked as a PhD researcher at the university of Helsinki where she designed and developed various oncolytic viruses for cancer immunotherapy. Leena earned her PhD in virology from the Faculty of Medicine at the University of Helsinki.